Arcutis Biotherapeutics, Inc. SEC filings ARQT
Arcutis Biotherapeutics, Inc. has 866 filings in SEC EDGAR's recent list, going back to Sep 9, 2019. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Apr 21, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 28, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 5, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 16, 2026 | Jul 15, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 9, 2026 | Jun 5, 2026 |
| 8-K | Current report | May 6, 2026 | May 6, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2026 | Feb 25, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 8, 2025 | Dec 3, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2025 | Oct 28, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 17, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 10, 2025 | Apr 10, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 13, 2025 | Jan 12, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 10, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Other events
|
Mar 4, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Material agreement
|
Feb 28, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 15, 2024 | Feb 12, 2024 |
| 8-K |
Current report
Other events
|
Jan 11, 2024 | Jan 11, 2024 |
| 8-K |
Current report
Other events
|
Dec 18, 2023 | Dec 15, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2023 | Nov 3, 2023 |
| 8-K |
Current report
Other events
|
Oct 23, 2023 | Oct 19, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Oct 19, 2023 | Oct 19, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 27, 2023 | Sep 27, 2023 |
| 8-K/A |
Amended current report
Officer or director change
|
Sep 7, 2023 | Aug 15, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 18, 2023 | Aug 15, 2023 |
| 8-K |
Current report
Material agreement
|
Aug 14, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2023 | Jun 2, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
May 24, 2023 | May 22, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Other events
|
Dec 16, 2022 | Dec 12, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Sep 7, 2022 | Sep 7, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 6, 2022 | Sep 2, 2022 |
| 8-K |
Current report
Other events
|
Aug 5, 2022 | Aug 2, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
New debt, Other events
|
Aug 2, 2022 | Jul 29, 2022 |
| 8-K |
Current report
Other events
|
Jun 9, 2022 | Jun 6, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2022 | Jun 1, 2022 |
| 8-K |
Current report
Results of operations
|
May 5, 2022 | May 5, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 22, 2022 | Feb 22, 2022 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure, Other events
|
Dec 23, 2021 | Dec 22, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Other events
|
Oct 4, 2021 | Oct 4, 2021 |
| 8-K |
Current report
Material agreement
|
Sep 28, 2021 | Sep 22, 2021 |
| 8-K |
Current report
Officer or director change
|
Sep 7, 2021 | Sep 3, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 14, 2021 | Jun 8, 2021 |
| 8-K |
Current report
Results of operations
|
May 4, 2021 | May 4, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 26, 2021 | Mar 22, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 16, 2021 | Feb 16, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 5, 2021 | Feb 1, 2021 |
| 8-K |
Current report
Other events
|
Feb 1, 2021 | Feb 1, 2021 |
| 8-K |
Current report
Material agreement
|
Jan 15, 2021 | Nov 24, 2020 |
| 8-K |
Current report
Other events
|
Nov 23, 2020 | Nov 23, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Officer or director change, Other events
|
Nov 4, 2020 | Oct 29, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 6, 2020 | Oct 1, 2020 |
| 8-K |
Current report
Other events
|
Sep 29, 2020 | Sep 29, 2020 |
| 8-K |
Current report
Other events
|
Sep 18, 2020 | Sep 16, 2020 |
| 8-K |
Current report
Other events
|
Sep 9, 2020 | Sep 8, 2020 |
| 8-K | Current report | Aug 11, 2020 | Aug 11, 2020 |
| 8-K |
Current report
Other events
|
Jul 31, 2020 | Jul 31, 2020 |
| 8-K |
Current report
Officer or director change
|
Jul 29, 2020 | Jul 23, 2020 |
| 8-K |
Current report
Results of operations
|
May 13, 2020 | May 12, 2020 |
| 8-K |
Current report
Material agreement
|
Apr 29, 2020 | Apr 22, 2020 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 27, 2020 | Apr 23, 2020 |
Showing 75 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARQT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Westlake Village, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1787306
- Former names
- Arcutis, Inc. (until Sep 9, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.